Autopsy report · NCT03593460

Phase II AutoImmune Hepatitis

“BioIncept changed the focus of future drug development”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Christopher O'Brien, MD

Sponsor type

University, hospital or other

Conditions

Hepatitis, Autoimmune

Interventions

Synthetic PreImplantation Factor

Participants

0

Trials that died the same way

• Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo
  “Changes in drug development plans” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.